107 related articles for article (PubMed ID: 38757972)
1. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972
[TBL] [Abstract][Full Text] [Related]
2. Site-specific glycosylation of Ebola virus glycoprotein by human polypeptide GalNAc-transferase 1 induces cell adhesion defects.
Simon EJ; Linstedt AD
J Biol Chem; 2018 Dec; 293(51):19866-19873. PubMed ID: 30389789
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
Lennemann NJ; Rhein BA; Ndungo E; Chandran K; Qiu X; Maury W
mBio; 2014 Jan; 5(1):e00862-13. PubMed ID: 24473128
[TBL] [Abstract][Full Text] [Related]
4. N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion.
Iraqi M; Edri A; Greenshpan Y; Kundu K; Bolel P; Cahana A; Ottolenghi A; Gazit R; Lobel L; Braiman A; Porgador A
Front Cell Infect Microbiol; 2020; 10():48. PubMed ID: 32211339
[TBL] [Abstract][Full Text] [Related]
5. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the
Hintze J; Ye Z; Narimatsu Y; Madsen TD; Joshi HJ; Goth CK; Linstedt A; Bachert C; Mandel U; Bennett EP; Vakhrushev SY; Schjoldager KT
J Biol Chem; 2018 Dec; 293(49):19064-19077. PubMed ID: 30327431
[TBL] [Abstract][Full Text] [Related]
6. Comparison of N- and O-linked glycosylation patterns of ebolavirus glycoproteins.
Collar AL; Clarke EC; Anaya E; Merrill D; Yarborough S; Anthony SM; Kuhn JH; Merle C; Theisen M; Bradfute SB
Virology; 2017 Feb; 502():39-47. PubMed ID: 27984785
[TBL] [Abstract][Full Text] [Related]
7. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
[TBL] [Abstract][Full Text] [Related]
8. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
[TBL] [Abstract][Full Text] [Related]
9. Glycan shield of the ebolavirus envelope glycoprotein GP.
Peng W; Rayaprolu V; Parvate AD; Pronker MF; Hui S; Parekh D; Shaffer K; Yu X; Saphire EO; Snijder J
Commun Biol; 2022 Aug; 5(1):785. PubMed ID: 35927436
[TBL] [Abstract][Full Text] [Related]
10. O-linked glycosylation of the mucin domain of the herpes simplex virus type 1-specific glycoprotein gC-1 is temporally regulated in a seed-and-spread manner.
Nordén R; Halim A; Nyström K; Bennett EP; Mandel U; Olofsson S; Nilsson J; Larson G
J Biol Chem; 2015 Feb; 290(8):5078-5091. PubMed ID: 25548287
[TBL] [Abstract][Full Text] [Related]
11. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.
Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM
J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723
[TBL] [Abstract][Full Text] [Related]
13. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.
Marzi A; Akhavan A; Simmons G; Gramberg T; Hofmann H; Bates P; Lingappa VR; Pöhlmann S
J Virol; 2006 Jul; 80(13):6305-17. PubMed ID: 16775318
[TBL] [Abstract][Full Text] [Related]
14. Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.
Martinez O; Tantral L; Mulherkar N; Chandran K; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S825-32. PubMed ID: 21987758
[TBL] [Abstract][Full Text] [Related]
15. Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.
Termini JM; Church ES; Silver ZA; Haslam SM; Dell A; Desrosiers RC
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747495
[TBL] [Abstract][Full Text] [Related]
16. New Perspectives on Ebola Virus Evolution.
Brown CJ; Quates CJ; Mirabzadeh CA; Miller CR; Wichman HA; Miura TA; Ytreberg FM
PLoS One; 2016; 11(8):e0160410. PubMed ID: 27479005
[TBL] [Abstract][Full Text] [Related]
17. Early steps in O-linked glycosylation and clustered O-linked glycans of herpes simplex virus type 1 glycoprotein C: effects on glycoprotein properties.
Biller M; Mårdberg K; Hassan H; Clausen H; Bolmstedt A; Bergström T; Olofsson S
Glycobiology; 2000 Dec; 10(12):1259-69. PubMed ID: 11159917
[TBL] [Abstract][Full Text] [Related]
18. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
Brockhausen I; Dowler T; Paulsen H
Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
[TBL] [Abstract][Full Text] [Related]
19. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.
Acciani MD; Lay Mendoza MF; Havranek KE; Duncan AM; Iyer H; Linn OL; Brindley MA
J Virol; 2021 Sep; 95(20):e0116521. PubMed ID: 34319156
[TBL] [Abstract][Full Text] [Related]
20. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
